A single Epioxa epi-on cross-linking treatment sustained a 1.9 D Kmax improvement through three years in keratoconus, with no ...
Combining corneal cross-linking with a refractive procedure can give patients with keratoconus both corneal stability and ...
Please provide your email address to receive an email when new articles are posted on . Optometrists are often first to diagnose a patient with keratoconus and hold a great responsibility for ...
Three-year data demonstrate sustained improvements in corneal shape, meaningful visual acuity gains, and a favorable ...
Arun C. Gulani, MD, introduces a keratoconus classification based on what prevents vision: visual, structural, or salvage.
To assess the clinical outcomes of Corneal Allogenic Intrastromal Ring Segments (CAIRS) as a therapeutic approach for keratoconus (KC), with a focus on visual acuity ...
Please provide your email address to receive an email when new articles are posted on . FRANKFURT, Germany — Corneal allogenic intrastromal ring segment implantation has more flattening effect on the ...
Glaukos Corporation (NYSE: GKOS) announced results from a long-term Phase 3 extension study evaluating its Epioxa corneal cross-linking therapy for keratoconus, showing sustained efficacy and safety ...
SEATTLE — Keeping our vision strong is important throughout life. Conditions like keratoconus, though, can cause vision to decline. “The cornea is important to be clear,” said Dr. Luke Barker of ...
Glaukos Corporation announced positive topline results from a long-term Phase 3 extension study (GLK-202-03) evaluating the durability, visual outcomes, and safety of Epioxa®, the company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results